Effective evaluation of combined treatment in delayed cerebrovascular spasm after subarachnoid hemorrhage

李聪慧,叶建亚,杜萍,张庆俊,张更申,孙国柱,张金峰,李建华,聂建刚
DOI: https://doi.org/10.19845/j.cnki.zfysjjbzz.2009.05.020
2009-01-01
Abstract:Objective To discuss the clinical effects of combined treatment of delayed cerebrovascular spasm(DCVS)after subarachnoid hemorrhage.Methods 96 cases with intracranial aneurysmal SAH were randomly divided into control group and therapeutic group.The patients in control group were given the routine treatment including Nimodipine 1~2mg/h pumping in continuely for 14 days.The patients in therapeutic group were given the same treatment and Edaravone at dose of 30mg twice a day for14 days,Methylprednisolone at dose of 30mg/(kg·d)for 7 days,Fasudil at dose of 30mg three times a day for 14 days.Lumbar puncture or ventricular puncture was given to drain bloody CSF.Vital signs were monitored continuously in all patients.Comparison of clinical data between per and post-therapy in the two groups was done by the statistical analysis,such as clinical manifestation,the level of consciousness as GCS,the conditions of patients as Hunt&Hess,clinical outcome as GOS and CT,TCD,MRI.Results There were no significantly different between two groups in grade of GCS,Hunt&Hess,Fisher pre-therapy(P>0.05).CT and MRI showed that the cases of cerebral infarction were 10(10.4%)in therapeutic group,lowed than 21(43.8%)in control group(P<0.05).TCD showed the mean blood flow of median cerebral artery(MCA)was(115.8±11.5)cm/s in control group and(112.5±12.1)cm/s in therapeutic group(1st day),and there was no difference between two groups(P>0.05).It were separately(158.9±13.6)cm/s on 3d,(199.4±17.2)cm/s on 7d and(129.5±14.4)cm/s on 14d in control group and(130.7±11.8)cm/s on 3d,(140.1±16.4)cm/s on 7d,and(116.7±13.9)cm/s on 14d in therapeutic group.Compared the results with that in control group the mean blood flow of MCA on 7d in therapeutic group was obviosly slower(P<0.05).Curative effect comparison showed significant effective rate in therapeutic group(75.0%)was higher than that in control group(52.1%)(P<0.05).Conclusion The combined treatment is a better way for DCVS after SAH.
What problem does this paper attempt to address?